Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
The Journal of Hand Surgery|September 11, 2007
Anthropometry of the human scaphoidAndrew D Heinzelmann, Graeme Archer, Randy R BindraJournal of Clinical Psychopharmacology|October 25, 2011
Results from 2 randomized, double-blind, placebo-controlled studies of the novel NK1 receptor antagonist casopitant in patients with major depressive disorderEmiliangelo Ratti, Kevin Bellew, Paolo Bettica, et al.Journal of Psychopharmacology (Oxford, England)|November 4, 2011
Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trialsSusan Learned, Ole Graff, Suraja Roychowdhury, et al.Sleep|December 3, 2013
Efficacy of vestipitant, a neurokinin-1 receptor antagonist, in primary insomniaEmiliangelo Ratti, David J Carpenter, Stefano Zamuner, et al.Journal of Psychopharmacology (Oxford, England)|March 30, 2013
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studiesEmiliangelo Ratti, Paolo Bettica, Robert Alexander, et al.Pageof 1